High early death rate in tuberculosis patients in Malawi

International Journal of Tuberculosis and Lung Disease

Volumn 5, Issue 11, 2001, Pages 1000-1005

  Harries, A D ^a   Hargreaves, N J ^a   Gausi, F ^a   Kwanjana, J H ^a   Salaniponi, F M ^a  

^a British High Commission Lilongwe   (Malawi)

Author keywords

Early deaths; Malawi; Tuberculosis

Indexed keywords

ETHAMBUTOL; ISONIAZID; PYRAZINAMIDE; RIFAMPICIN; STREPTOMYCIN; TUBERCULOSTATIC AGENT;

ADULT; AGE; AGING; ARTICLE; CAUSE OF DEATH; CHILD; FEMALE; HOSPITAL ADMISSION; HUMAN; LUNG TUBERCULOSIS; MALAWI; MALE; MORTALITY; PRIORITY JOURNAL; PUBLIC HOSPITAL; REGISTER; RETROSPECTIVE STUDY; SPUTUM SMEAR; TREATMENT OUTCOME;

ADOLESCENT; ADULT; AGED; ANTITUBERCULAR AGENTS; FEMALE; HUMANS; MALAWI; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; TIME FACTORS; TUBERCULOSIS;

EID: 0035208053     PISSN: 10273719     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Issues facing TB control: Tuberculosis control in sub-Saharan Africa in the face of HIV and AIDS
2. Efficacy of trimethoprim-sulphamethoxazole prophylaxis to decrease morbidity and mortality in HIV-1 infected patients with tuberculosis in Abidjan, Cote d'Ivoire: A randomised controlled trial
3. Cohort study of human immunodeficiency virus infection in patients with tuberculosis in Nairobi, Kenya
4. Treatment outcome of an unselected cohort of tuberculosis patients in relation to human immunodefiency virus serostatus in Zomba hospital, Malawi
5. Impact of human immunodeficiency virus epidemic on mortality among adults with tuberculosis in rural South Africa, 1991-1995
6. High mortality rates among patients with tuberculosis in Bangui, Central African Republic
7. Survival of human immunodeficiency virus-infected persons with pulmonary tuberculosis
8. Treatment of Tuberculosis
9. Randomised trial of thiacetazone and rifampicin-containing regimens for pulmonary tuberculosis in HIV-infected Ugandans
10. The impact of human immunodeficiency virus on mortality of patients treated for tuberculosis in a cohort study in Zambia
11. Human immunodeficiency virus and the outcome of treatment for new and recurrent pulmonary tuberculosis in African patients
12. Factors associated with an increased case-fatality rate in HIV-infected and non-infected South African gold miners with pulmonary tuberculosis
13. Evaluation of a unified treatment regimen for all new cases of tuberculosis using guardian-based supervision
14. Cause of death in patients admitted to hospital for pulmonary tuberculosis
15. Corticosteroids and tuberculosis: Risks and use as adjunct therapy
16. Double blind randomised placebo controlled trial of adjunctive prednisolone in the treatment of effusive tuberculous pericarditis
17. Micronutrients and HIV-1 disease progression
18. Association between serum vitamin A and E levels and HIV-1 disease progression